Does Time-to-Chemotherapy after Primary Complete Macroscopic Cytoreductive Surgery Influence Prognosis for Patients with Epithelial Ovarian Cancer? A Study of the FRANCOGYN Group

To determine if the time-to-chemotherapy (TTC) after primary macroscopic complete cytoreductive surgery (CRS) influences recurrence-free survival (RFS) and overall survival (OS) in patients with epithelial ovarian cancer (EOC). We conducted an observational multicenter retrospective cohort analysis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Rocher, Grégoire, Gaillard, Thomas, Uzan, Catherine, Collinet, Pierre, Bolze, Pierre-Adrien, Ballester, Marcos, Bendifallah, Sofiane, Ouldamer, Lobna, Touboul, Cyril, Huchon, Cyrille, Lavoue, Vincent, Dabi, Yohann, Akladios, Cherif, Coutant, Charles, Raimond, Emilie, Bricou, Alexandre, Canlorbe, Geoffroy, Azaïs, Henri
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961531/
https://ncbi.nlm.nih.gov/pubmed/33806443
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10051058
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars